GILD - GILEAD SCIENCES, INC.


147.83
-2.200   -1.488%

Share volume: 6,356,236
Last Updated: 03-03-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.31%

PREVIOUS CLOSE
CHG
CHG%

$150.03
-2.20
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 05-08-2024 08-08-2024 11-12-2024 02-28-2025 05-07-2025 08-07-2025 11-07-2025 02-24-2026
Cash flow financing -1.361 B -2.953 B -1.379 B 2.260 B -3.426 B -1.567 B -1.489 B -1.263 B
Other financing cash flows 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Cash flow -1.349 B -1.935 B 2.220 B 5.010 B -2.084 B -2.856 B 2.192 B 229.000 M
Net income -4.170 B 1.614 B 1.253 B 1.783 B 1.315 B 1.960 B 3.052 B 2.183 B
Depreciation 94.000 M 98.000 M 94.000 M 95.000 M 97.000 M 93.000 M 90.000 M 90.000 M
Changes in inventories 45.000 M 0.000 0.000 0.000 223.000 M 0.000 0.000 0.000
Changes in receivables 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Cashflow -2.207 B -307.000 M -710.000 M -225.000 M -415.000 M -2.116 B -427.000 M -1.835 B
Net Borrowings 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Activity Other 5.000 M 7.000 M 11.000 M 35.000 M -23.000 M 10.000 M 4.000 M 11.000 M
Dividends Paid -990.000 M -972.000 M -983.000 M -973.000 M -1.010 B -994.000 M -1.005 B -994.000 M
Exchange Rate Effect 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Capital Expenditures 105.000 M 130.000 M 141.000 M 147.000 M 104.000 M 107.000 M 147.000 M 205.000 M
Cash Change -1.367 B -1.946 B 2.264 B 4.955 B -2.065 B -2.783 B 2.187 B 233.000 M